HIV & AIDS

HIV can develop resistance to CRISPR/Cas9

The CRISPR/Cas9 gene-editing platform may need a little bit more tweaking before it can be used as an effective antiviral, reports a study published April 7 in Cell Reports. Researchers who used CRISPR/Cas9 to mutate HIV-1 ...

Oncology & Cancer

Researchers see helpful protein causing cancer

Washington State University researchers have determined how a protein that helps cells fight viruses can also cause genetic mutations that lead to cancer.

page 24 from 40